Literature DB >> 24083742

GPR48 promotes multiple cancer cell proliferation via activation of Wnt signaling.

Yong-Bin Zhu1, Lin Xu, Ming Chen, Hai-Na Ma, Fang Lou.   

Abstract

The key signaling networks regulating cancer cell proliferation remain to be defined. The leucine-rich repeat containing G-protein coupled receptor 48 (GPR48) plays an important role in multiple organ development. In the present study, we investigated whether GPR48 functions in cancer cells using MCF-7, HepG2, NCI-N87 and PC-3 cells. We found that GPR48 overexpression promotes while its knockdown using small interfering RNA oligos inhibits cell proliferation. In addition, Wnt/β-catenin signaling was activated in cells overexpressing GPR48. Therefore, our results indicated that GPR48 activates Wnt/β-catenin signaling to regulate cancer cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24083742     DOI: 10.7314/apjcp.2013.14.8.4775

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  9 in total

1.  GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.

Authors:  Fang Liang; Junmin Yue; Junyong Wang; Lijuan Zhang; Rui Fan; Hao Zhang; Qingsong Zhang
Journal:  Med Oncol       Date:  2015-01-31       Impact factor: 3.064

2.  RANKL regulates testicular cancer growth and Denosumab treatment has suppressive effects on GCNIS and advanced seminoma.

Authors:  Christine Hjorth Andreassen; Mette Lorenzen; John E Nielsen; Sam Kafai Yahyavi; Birgitte Grønkær Toft; Lars R Ingerslev; Christoffer Clemmensen; Lene Juel Rasmussen; Carsten Bokemeyer; Anders Juul; Anne Jørgensen; Martin Blomberg Jensen
Journal:  Br J Cancer       Date:  2022-04-13       Impact factor: 9.075

3.  R-spondin3-LGR4 signaling protects hepatocytes against DMOG-induced hypoxia/reoxygenation injury through activating β-catenin.

Authors:  Shiying Liu; Yue Yin; Ruili Yu; Yin Li; Weizhen Zhang
Journal:  Biochem Biophys Res Commun       Date:  2018-03-19       Impact factor: 3.575

Review 4.  The Role of LGR4 (GPR48) in Normal and Cancer Processes.

Authors:  Alejandro Ordaz-Ramos; Victor Hugo Rosales-Gallegos; Jorge Melendez-Zajgla; Vilma Maldonado; Karla Vazquez-Santillan
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

5.  Targeted deletion of the murine Lgr4 gene decreases lens epithelial cell resistance to oxidative stress and induces age-related cataract formation.

Authors:  Jun Zhu; Qiang Hou; Xiang Da Dong; Zhenlian Wang; Xiaoyan Chen; Dandan Zheng; Linglin Zhou; Chao He; Mingyao Liu; LiLi Tu; Jia Qu
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

Review 6.  RANK-RANKL signalling in cancer.

Authors:  Nathalie Renema; Benjamin Navet; Marie-Françoise Heymann; Frédéric Lezot; Dominique Heymann
Journal:  Biosci Rep       Date:  2016-08-05       Impact factor: 3.840

7.  LGR4 Is a Direct Target of MicroRNA-34a and Modulates the Proliferation and Migration of Retinal Pigment Epithelial ARPE-19 Cells.

Authors:  Qiang Hou; Linglin Zhou; Jiajia Tang; Nan Ma; Ancong Xu; Jiang Tang; Dandan Zheng; Xiaogang Chen; Feng Chen; Xiang Da Dong; LiLi Tu
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

Review 8.  Emerging Roles for LGR4 in Organ Development, Energy Metabolism and Carcinogenesis.

Authors:  Linlin Yang; Jing Wang; Xiaodi Gong; Qiong Fan; Xiaoming Yang; Yunxia Cui; Xiaoyan Gao; Lijuan Li; Xiao Sun; Yuhong Li; Yudong Wang
Journal:  Front Genet       Date:  2022-01-24       Impact factor: 4.599

9.  Upregulation of RSPO2-GPR48/LGR4 signaling in papillary thyroid carcinoma contributes to tumor progression.

Authors:  Yea Eun Kang; Jin-Man Kim; Koon Soon Kim; Joon Young Chang; Mingyu Jung; Junguee Lee; Shinae Yi; Hyeon Woo Kim; Jung Tae Kim; Kyungmin Lee; Min Jeong Choi; Seul Ki Kang; Seong Eun Lee; Hyon-Seung Yi; Bon Seok Koo; Minho Shong
Journal:  Oncotarget       Date:  2017-11-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.